Authors
Loading...
Review explores how selective COX-2 inhibitors increase cardiovascular risks through thrombosis and inflammation pathways.
Asela Berenice López-Cuellar (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: